UCSF Launches Translational Psychedelic Research (TrPR) Program April 9, 2021
The newly christened Translational Psychedelic Research (TrPR) Program is launching a unique multidisciplinary network of scientists and healthcare providers who work together to research psychedelic-assisted therapies.
The TrPR Program, which is based at UCSF, is distinguishing itself from other university research groups through its distinctively inclusive approach to psychedelic medicine. Members of the TrPR network study psychedelic therapies that may benefit patients with conditions considered higher risk or overlooked by other researchers in the field, such as bipolar disorder, Parkinson’s and back pain.
TrPR includes investigators from both clinical and research disciplines based at medical centers from the San Francisco Bay Area to Seattle, says Dr. Joshua Woolley Associate Professor of Psychiatry at the UCSF Weill Institute for Neurosciences and Director of the Translationa
San-francisco-state-university
California
United-states
Berkeley
United-kingdom
British
Michael-silver
Cassie-nielsen
Ellen-bradley
Boris-heifets
Erin-michalak
Robin-carhart-harris